Merck KGaA (MKGAF)
162.95
+7.50
(+4.82%)
USD |
OTCM |
Oct 06, 16:00
Merck Profit Margin (Quarterly) : 9.09% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.09% |
| March 31, 2026 | 13.03% |
| December 31, 2025 | 6.17% |
| September 30, 2025 | 16.89% |
| June 30, 2025 | 12.46% |
| March 31, 2025 | 13.98% |
| December 31, 2024 | 12.35% |
| September 30, 2024 | 15.42% |
| June 30, 2024 | 11.30% |
| March 31, 2024 | 13.65% |
| December 31, 2023 | 11.25% |
| September 30, 2023 | 14.30% |
| June 30, 2023 | 13.32% |
| March 31, 2023 | 15.11% |
| December 31, 2022 | 11.64% |
| September 30, 2022 | 15.95% |
| June 30, 2022 | 15.62% |
| March 31, 2022 | 17.01% |
| December 31, 2021 | 15.48% |
| September 30, 2021 | 15.36% |
| June 30, 2021 | 15.34% |
| March 31, 2021 | 16.15% |
| December 31, 2020 | 9.59% |
| September 30, 2020 | 18.12% |
| June 30, 2020 | 7.02% |
| Date | Value |
|---|---|
| March 31, 2020 | 10.48% |
| December 31, 2019 | 7.69% |
| September 30, 2019 | 8.36% |
| June 30, 2019 | 10.60% |
| March 31, 2019 | 5.31% |
| December 31, 2018 | 4.95% |
| September 30, 2018 | 8.62% |
| June 30, 2018 | 6.57% |
| March 31, 2018 | 9.55% |
| December 31, 2017 | 28.26% |
| September 30, 2017 | 17.63% |
| June 30, 2017 | 11.15% |
| March 31, 2017 | 13.55% |
| December 31, 2016 | 6.92% |
| September 30, 2016 | 12.35% |
| June 30, 2016 | 8.25% |
| March 31, 2016 | 16.18% |
| December 31, 2015 | 3.52% |
| September 30, 2015 | 11.72% |
| June 30, 2015 | 10.74% |
| March 31, 2015 | 9.38% |
| December 31, 2014 | 9.40% |
| September 30, 2014 | 8.55% |
| June 30, 2014 | 10.87% |
| March 31, 2014 | 12.46% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Bayer AG | 2.11% |
| Dermapharm Holding SE | 8.12% |
| AstraZeneca PLC | 20.15% |
| GSK Plc | 6.58% |
| Johnson & Johnson | 21.86% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 8.19% |
| Return on Assets | 4.67% |
| Return on Invested Capital | 5.87% |
| Gross Profit Margin (Quarterly) | 58.26% |
| Operating Margin (Quarterly) | 21.51% |
| Return on Net Operating Assets | 5.42% |